Prisons Keep Hepatitis C Cures Under Lock and Key
State prisoners have a higher-than-average rate of hepatitis C infection, but their chances of accessing a cure are uncommonly slim. A new study from Health Affairs reveals that less than 1 percent of prisoners with hepatitis C can get direct-acting antiviral treatments for the chronic disease. The study included 106,200 inmates across 41 state prison systems.
VA Expands Veterans’ Access to Hepatitis C Cures
Treatment options for U.S. veterans battling hepatitis C just got better.
Research Predicts Cures’ Impact on Hepatitis C Population
The near elimination of hepatitis C could be in sight, suggests new research from Yale University.
CMS Notice Urges Access to Hepatitis C Cures for Medicaid Patients
The Centers for Medicare and Medicaid Services has a message for state Medicaid programs: coverage policies cannot block hepatitis C patients’ access to “effective, clinically appropriate and medically necessary treatments.”
New AfPA Video Considers Access Barriers to Hepatitis C Cures
Since 2013 a new series of medications has offered patients with hepatitis C something radical – a 90 to 99 percent cure rate.
New Study: 1 in 4 Patients Initially Denied Hepatitis C Cures
Hepatitis C patients have a one in four chance of receiving curative treatment on their initial request, a new Yale University School of Medicine study reveals.
Curing Seniors’ Hepatitis C Early Could Cut Medicare Costs, Save Lives
Curing hepatitis C before senior citizens age into Medicare could save tens of thousands of lives. And as a new study from Milliman reports, it could also save the Medicare system $3.9 billion over 10 years.
IfPA White Paper Explores Patient Access to Hepatitis C Cures
New cures have stirred high hopes for the millions of Americans infected with hepatitis C.
New Study Questions Medicaid Rationing of Hepatitis C Cures
A new study published in the Annals of Internal Medicine raises a provocative question about hepatitis C care: Does state rationing of new cures violate federal Medicaid law? The study, released June 30, examines which states limit Medicaid patients’ access to the hepatitis C cure sofosbuvir.
VA Plan to Outsource Hepatitis C Treatment for Veterans Draws Backlash
The U.S. Department of Veterans Affairs may soon join the ranks of entities curbing patient access in an attempt to balance the budget.
